COMMUNIQUÉS West-GlobeNewswire

Healthmap Solutions Acquires Carium to Enhance Digital Engagement Capabilities within Healthmap’s Population Health Management Platform
06/02/2025
TAMPA, Fla., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Healthmap Solutions, Inc. (Healthmap), an industry-leading kidney population health management company, has announced its acquisition of Carium, a digital care management [...]
USAHS Welcomes a Preeminent Expert to Lead Occupational Therapy Programs
06/02/2025
The University plans to continue expanding and refining its OT curriculum across all five of its campuses DALLAS, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The University of St. Augustine for Health Sciences (USAHS) proudly [...]
North Texas Took Center Stage at Advanced Therapies Week 2025, Highlighting Innovation and Collaboration in Life Sciences
06/02/2025
DALLAS, Feb. 06, 2025 (GLOBE NEWSWIRE) -- From January 20-23, 2025, North Texas took center stage as a global hub for innovation during Advanced Therapies Week (ATW) 2025. This signature event showcased the intersection [...]
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
06/02/2025
AUDUBON, Pa. and REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical device company that is [...]
BioAdaptives Welcomes UFC Senior Executive Reed Harris to Its Board of Advisors
06/02/2025
Harris, the Senior Vice President of Athlete Development and Marketing at the Ultimate Fighting Championship, has a distinguished career spanning over 40 years LAS VEGAS, Feb. 06, 2025 (GLOBE NEWSWIRE) -- via IBN – [...]
Intelligent Bio Solutions expects to achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin Sales
06/02/2025
Gross profit expected to surge by 32.6% Unaudited revenue of $0.61 million for fiscal Q2 and $1.48 million for the six months ended December 31, 2024 Higher-margin cartridge sales driving profitability and long-term [...]
Gain Therapeutics CEO Gene Mack Issues Letter To Shareholders and Provides Operational Update
06/02/2025
BETHESDA, Md., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of [...]
Catheter Precision to Attend and Participate in the 13th Internation Symposium on Left Atrial Appendage
06/02/2025
FORT MILL, S.C., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac [...]
CytoDyn Announces Findings of Statistically Significant Fibrosis Reversal Across Studies with SMC Laboratories
06/02/2025
VANCOUVER, Washington, Feb. 06, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple [...]
Myriad Genetics and CancerCARE for Life Announce Agreement to Advance Access to MyRisk with RiskScore Hereditary Cancer Test
06/02/2025
SALT LAKE CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, and INTERLINK Care Management, Inc. announced an agreement [...]
e-therapeutics présentera des données précliniques relatives à l’ETX-148 lors de l’édition 2025 du Congrès annuel de l’EAHAD
05/02/2025
LONDRES, 05 févr. 2025 (GLOBE NEWSWIRE) -- e-therapeutics plc, une entreprise qui conjugue la puissance informatique aux données biologiques en vue de mettre au point des nouveaux médicaments ARNi, annonce ce jour son [...]
STERIS Announces Financial Results for Fiscal 2025 Third Quarter
05/02/2025
Total revenue from continuing operations increased 6%; constant currency organic revenue grew 6% As reported diluted EPS from continuing operations increased to $1.75; adjusted EPS increased to $2.32 Fiscal 2025 outlook [...]
Myriad Genetics Announces Two New Patents Granted for its Molecular Residual Disease (MRD) Assay
05/02/2025
SALT LAKE CITY, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in genetic and tumor genomic testing and precision medicine, announced that the United States Patent and Trademark Office [...]
DLH Reports Fiscal 2025 First Quarter Results
05/02/2025
Navigating Challenges in Company's Transformation Journey; Delivering Recent Wins and Growing Bid Pipeline to Improve Outlook for Organic Growth ATLANTA, Feb. 05, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: [...]
The Ensign Group Reports Fiscal Year and Fourth Quarter 2024 Results; Issues 2025 Earnings Guidance
05/02/2025
Conference Call and Webcast scheduled for tomorrow, February 6, 2025 at 10:00 am PT SAN JUAN CAPISTRANO, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign [...]
BriaCell Therapeutics Announces Closing of Public Offering
05/02/2025
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 05, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that [...]
Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
05/02/2025
FOSTER CITY, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025
05/02/2025
RADNOR, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD [...]
Cytek Biosciences to Participate in Upcoming Investor Conferences
05/02/2025
FREMONT, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor [...]

Pages